Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Clinical Investigations

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

Abraham, Edward MD; Laterre, Pierre-François MD; Garbino, Jorge MD; Pingleton, Susan MD; Butler, Thomas MD; Dugernier, Thierry MD; Margolis, Benjamin MD; Kudsk, Kenneth MD; Zimmerli, Werner MD; Anderson, Paula MD; Reynaert, Marc MD; Lew, Daniel MD; Lesslauer, Werner MD, PRPN; Cooper, Sharon Passe; Philip PhD; Burdeska, Alex PhD; Modi, Marlene PhD; Leighton, Anton MD; Salgo, Miklos MD; Van der Auwera, Philippe MD for the Lenercept Study Group

Author Information
  • Buy

Abstract

© 2001 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins